MarcosIgnacioRestrepoMD
Pulmonology • San Antonio, TXCritical Care Medicine, Infectious Disease, Pleural Disease
Associate Professor, Medicine, University of Texas Medical School, San Antonio
Are you Dr. Restrepo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7400 Merton Minter Blvd
San Antonio, TX 78229Phone+1 210-617-5300Fax+1 210-567-4423
Summary
- Dr. Marcos Restrepo, MD is a pulmonologist in San Antonio, Texas. He is currently licensed to practice medicine in Indiana. He is affiliated with Audie L. Murphy Memorial Veterans' Hospital and is an Associate Professor at University of Texas Medical School.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2004- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Infectious Disease, 2000 - 2002
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1997 - 2000
Institute of Health Sciences Medellin Faculty of MedicineClass of 1991
Certifications & Licensure
IN State Medical License 2004 - 2025- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Efficacy of Macrolide Immunomodulation in Severe Sepsis. Start of enrollment: 2007 Nov 01
- Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- 95 citationsGlobal initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort studyStefano Aliberti, Luis F. Reyes, Paola Faverio, Giovanni Sotgiu, Simone Dore
The Lancet. Infectious Diseases. 2016-12-01 - 23 citationsMultidrug-resistant pathogens in patients with pneumonia coming from the community.Oriol Sibila, Ana Rodrigo-Troyano, Yuichiro Shindo, Stefano Aliberti, Marcos I. Restrepo
Current Opinion in Pulmonary Medicine. 2016-05-01 - 16 citationsAirway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.Oriol Sibila, Laia Garcia-Bellmunt, Jordi Giner, Ana Rodrigo-Troyano, Guillermo Suarez-Cuartin
Annals of the American Thoracic Society. 2016-05-04
Press Mentions
Immunologic Resilience: A New Metric to Accurately Gauge Covid-19’s PathSeptember 9th, 2021- COVID-19 Reflection & Healing at the San Antonio VAApril 15th, 2021
Grant Support
- Effect Of Macrolides As Immunomodulators In Patients With Sepsis And PneumoniaNational Heart, Lung, And Blood Institute2010–2011
